Detalhe da pesquisa
1.
Immunometabolic Status of COVID-19 Cancer Patients.
Physiol Rev
; 100(4): 1839-1850, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32721181
2.
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Ann Oncol
; 2024 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38857846
3.
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.
Ann Oncol
; 33(1): 57-66, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624497
4.
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
Breast Cancer Res Treat
; 190(3): 415-424, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546500
5.
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].
Ann Oncol
; 33(4): 454, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086737
6.
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
Int J Cancer
; 139(12): 2859-2864, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27578417
7.
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma.
Ann Oncol
; 27(2): 274-80, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26578734
8.
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.
Ann Oncol
; 26(10): 2079-84, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209642
9.
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
ESMO Open
; 9(3): 102390, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460249
10.
Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.
Ann Oncol
; 24(12): 3028-34, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24190964
11.
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer.
Pharmacogenomics J
; 13(2): 159-72, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22158331
12.
Pilot scale validation campaign of gel dosimetry for pre-treatment quality assurance in stereotactic radiotherapy.
Phys Med
; 114: 103158, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806152
13.
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
ESMO Open
; 8(1): 100777, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36731325
14.
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.
Sci Rep
; 13(1): 12255, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507480
15.
Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'.
Ann Oncol
; 23(6): 1416-21, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052988
16.
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO.
Trials
; 23(1): 969, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36457115
17.
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers.
ESMO Open
; 7(6): 100645, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455507
18.
Reply to the letter to the editor 'A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma' by Hines et al.
Ann Oncol
; 27(6): 1171, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26912556
19.
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).
Ann Oncol
; 22(11): 2424-2430, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21385884
20.
Correction to Lancet Oncol 2015; 16: 747. EGFR mutations and EGFR tyrosine kinase inhibitors.
Lancet Oncol
; 16(7): e313, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149882